|
| 35814719 | Consumption of industrial processed foods and risk of premenopausal breast cancer among Latin American women: the PRECAMA study. | BMJ Nutr Prev Health | 2022 |
| 35347551 | Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ. | Breast Cancer Res Treat | 2022 |
| 34312396 | Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. | NPJ Breast Cancer | 2021 |
| 33762354 | Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma <i>In Situ</i>. | Cancer Res | 2021 |
| 33753452 | Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer. | Clin Cancer Res | 2021 |
| 34033488 | Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics. | J Proteome Res | 2021 |
| 31628796 | Female breast cancer risk in Bryansk Oblast, Russia, following prolonged low dose rate exposure to radiation from the Chernobyl power station accident. | Int J Epidemiol | 2020 |
| 30539315 | Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma. | Cancer Causes Control | 2019 |
| 31661737 | Project profile: a multicenter study on breast cancer in young women in Latin America (PRECAMA study). | Salud Publica Mex | 2019 |
| 31657982 | Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial. | J Clin Oncol | 2019 |
| 31434678 | RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. | Genome Res | 2019 |
| 30324461 | Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC). | Mol Imaging Biol | 2019 |
| 30653559 | Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study. | PLoS One | 2019 |
| 29339357 | Family History and Risk of Second Primary Breast Cancer after <i>In Situ</i> Breast Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 30166604 | Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. | Sci Rep | 2018 |
| 31360852 | Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ. | JNCI Cancer Spectr | 2018 |
| 29588392 | Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial. | Mol Cancer Ther | 2018 |
| 29378785 | The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 29708591 | Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancer. | Int J Cancer | 2018 |
| 29254937 | Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 29092024 | Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. | Ann Oncol | 2018 |
| 27852699 | Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues. | Clin Cancer Res | 2017 |
| 26878076 | An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS. | Analyst | 2016 |
| 26419306 | ACR BI-RADS Use in Low-Income Countries: An Analysis of Diagnostic Breast Ultrasound Practice in Uganda. | J Am Coll Radiol | 2016 |
| 27325412 | Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System. | Acad Radiol | 2016 |
| 27440541 | Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China. | Nutr Res | 2016 |
| 27220749 | Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer. | Breast Cancer Res Treat | 2016 |
| 27307466 | Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 26744477 | Screening MRI in Women With a Personal History of Breast Cancer. | J Natl Cancer Inst | 2016 |
| 26801247 | Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer. | Clin Cancer Res | 2016 |
| 25698062 | An international study to increase concordance in Ki67 scoring. | Mod Pathol | 2015 |
| 25708638 | ToF-SIMS of tissues: "lessons learned" from mice and women. | Biointerphases | 2015 |
| 24170452 | A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC). | Mol Imaging Biol | 2014 |
| 25587029 | Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy. | Oncotarget | 2014 |
| 25291178 | Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. | PLoS One | 2014 |
| 24748570 | Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74Â years of age. | Breast Cancer Res Treat | 2014 |
| 24633144 | Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. | Cancer Epidemiol Biomarkers Prev | 2014 |
| 23224237 | Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. | Breast Cancer Res Treat | 2013 |
| 24303285 | Biotrust: a comprehensive system for acquiring and distributing biospecimens. | AMIA Jt Summits Transl Sci Proc | 2013 |
| 23833125 | Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. | Cancer Epidemiol Biomarkers Prev | 2013 |
| 23921840 | Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. | JAMA Intern Med | 2013 |
| 23812955 | Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. | J Natl Cancer Inst | 2013 |
| 23224272 | Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. | Cancer Causes Control | 2013 |
| 21752925 | Assessment of palindromes as platforms for DNA amplification in breast cancer. | Genome Res | 2012 |
| 22863786 | Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. | Nat Med | 2012 |
| 22367215 | Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. | Cancer Res | 2012 |
| 22366170 | Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. | Ann Epidemiol | 2012 |
| 22369929 | Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. | Cancer Res | 2012 |
| 20878463 | Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer. | Breast Cancer Res Treat | 2011 |
| 21960690 | Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer. | Cancer Epidemiol Biomarkers Prev | 2011 |